JPRN-UMIN000003977已完成2 期
Islet transplantation using brain-dead donors and donors after cardiac death for patients with insulin-dependent diabetes mellitus suffering from complicating hypoglycemia unawareness - Islet transplantation using brain-dead donors and donors after cardiac death for type 1 diabetes
The Japanese Pancreas and Islet Transplantation Association0 个研究点目标入组 9 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.BMI > 27 kg/m2 or weight > 80 kg. 2.Insulin requirement of > 0.8 IU/kg/day or 55 U/day. 3.Mean HbA1c value of several measurements in the previous 12 months > 10%. 4.Untreated proliferative diabetic retinopathy. 5.Blood pressure: SBP > 160 mmHg or DBP > 100 mmHg. 6.Creatinine clearance < 60 mL/min (applied only to islet transplantation alone case) 7.Presence of proteinuria > 1 g/day. 8.For female participants: Positive pregnancy test, presently breast-feeding, or unwillingness to use effective contraceptive measures for the duration of the study and 3 months after discontinuation. For male participants: Intent to procreate during the duration of the study or within 3 months after discontinuation or unwillingness to use effective measures of contraception. Oral contraceptives, Norplant, Depo-Provera, and barrier devices with spermicide are acceptable contraceptive methods; condoms used alone are not acceptable. 9.Active infection including hepatitis B, hepatitis C, HIV, or TB as determined by a positive skin test or clinical presentation, or under treatment for suspected TB. Positive tests are acceptable only if associated with a history of previous vaccination in the absence of any sign of active infection. Positive tests are otherwise not acceptable, even in the absence of any active infection at the time of evaluation. 10.Negative screen for Epstein-Barr Virus (EBV) by IgG determination. 11.Difficulty of administration for laboratory and physical tests for evaluation or regular outpatient visits. 12.Mental abnormalities to hinder medical procedure under protocol (Assessment by psychiatrists is required and final decision is made by investigators in charge) 13.Any medical condition that, in the opinion of the investigator, will interfere with the safe completion of the trial.
研究者
相似试验
已完成
2 期
Islet transplantation using brain-dead donors and donors after cardiac death for patients with insulin-dependent diabetes mellitus suffering from complicating hypoglycemia unawarenessJPRN-jRCTa071190048Eguchi Susumu10
已完成
2 期
Islet transplantation using brain-dead donors and donors after cardiac death for patients with insulin-dependent diabetes mellitus suffering from complicating hypoglycemia unawarenessInsulin-dependent diabetes mellitus suffering from complicating hypoglycemia unawarenessInsulin-dependent diabetes mellitusJPRN-jRCTa021190016Marubashi Shigeru9
招募中
不适用
Clinical Study of Allogeneic Islet Transplantation for Treatment of type 1 diabetesType 1 DiabetesJPRN-UMIN000014381ational Center for Global Health and Medicine3
招募中
2 期
Islet transplantation for insulin-dependent diabetes mellitusDiabetes Mellitus, Type 1JPRN-jRCTa030190164soejima yuuji10
招募中
2 期
islet transplantation for insulin-dependent diabetes mellitusinsulin-dependent diabets mellitusJPRN-UMIN000019471Shinshu University10